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AbstrACt
Introduction Two major global health challenges are 
the rapidly ageing population and the high prevalence of 
obesity in all age groups. Older adults are also susceptible 
to age-related loss of muscle strength, termed dynapaenia. 
The co-occurrence of both obesity and dynapaenia, 
termed dynapaenic obesity (DO), has been associated 
with poorer health outcomes and increased healthcare 
usage compared with either state alone. The purpose 
of this systematic review is to quantify the prevalence 
and incidence of DO in older adult populations, and to 
explore the association between DO and health outcomes, 
specifically chronic disease and multimorbidity, functional 
disability and healthcare usage.
Methods and analysis Using the Meta-analyses Of 
Observational Studies in Epidemiology guidelines, we 
will conduct a systematic review of cross-sectional 
and longitudinal observational studies of older adults, 
which include measures of DO and specified outcomes. 
Detailed literature searches of will be conducted using 
six electronic databases: Excerpta Medica dataBASE 
(EMBASE), PubMed, MEDLINE, SCOPUS, ScienceDirect and 
Cumulative Index of Nursing and Allied Health Complete 
(CINAHL), including articles published from database 
inception until Febuary 2019. The reference lists of 
included articles will also be searched. Two independent 
reviewers will undertake a three-step screening and 
review process using the Population, Risk Factor, Outcome 
framework to define eligibility. The Newcastle Ottawa 
Scale for non-randomised studies will be used to assess 
risk of bias and to rate study quality. The findings will be 
synthesised in a narrative summary, and a meta-analysis 
will be conducted where appropriate.
Ethics and dissemination Ethical approval is not 
required for this systematic review. Findings from this 
research will be submitted for peer-reviewed publication 
in academic journals, and presented at relevant academic 
conferences.
PrOsPErO registration number CRD42018112471.
IntrOduCtIOn
background
Two major societal challenges at a global level 
are the rapidly ageing population and the 
continual rise in obesity prevalence in people 
of all ages.1 2 The double burden of ageing 
and obesity therefore potentially represents 
a looming health sector crisis, whereby a 
greater number of older adults are living with 
multimorbidity3 and disability, much of which 
is related to modifiable risk factors such as 
obesity.
Evidence regarding the effect of obesity on 
morbidity and mortality in older populations 
is conflicting. While obesity is a recognised 
risk factor for chronic diseases such as 
cardiovascular disease, diabetes and some 
cancers,2 a number of studies have suggested 
that excess weight may be protective against 
adverse outcomes in many chronic condi-
tions. This phenomenon is referred to as the 
‘obesity paradox’4 and is based on the use of 
body mass index (BMI) to measure obesity. 
BMI is an imperfect measure in older adults 
as weight stability, or even weight loss, may 
mask an increase in fat mass and the redis-
tribution of fat to the abdominal area.5 This 
central or visceral accumulation of fat mass 
strengths and limitations of this study
 ► This is the first systematic review to investigate the 
frequency of dynapaenic obesity (DO) and associat-
ed health outcomes in older adult populations.
 ► This review will benefit from a comprehensive 
search of six electronic health and biomedical data-
bases using an extensive search strategy.
 ► We expect heterogeneity between studies in terms 
of both the criteria for classification of DO and the 
reporting of health .outcomes, which may lead to 
difficulties in conducting a meta-analysis.
 ► Results of this review will help to establish if DO is 
a significant risk factor for poor health outcomes in 
older adults, and may contribute to the design of fu-
ture interventions to target those most at risk of this 
phenotype and its negative effects.









pen: first published as 10.1136/bm





2 Leahy S, et al. BMJ Open 2019;9:e027728. doi:10.1136/bmjopen-2018-027728
Open access 
is more strongly associated with cardiometabolic disease 
than fat deposited at peripheral sites.6 Waist circumfer-
ence (WC) measures, or a combination of WC and BMI, 
may therefore be a more useful measure of body compo-
sition in older adult populations.
In addition to changes in fat mass and its distribution, 
ageing is associated with a gradual decline in muscle 
mass, termed sarcopaenia and muscle strength, termed 
dynapaenia.7 Measures of sarcopaenia and dynapaenia 
are increasingly being investigated as predictors of 
functional decline and health outcomes in studies of 
older adults.8 However, as with the measurement of fat 
mass, it is difficult to directly measure sarcopaenia in 
large samples or routine clinical settings. Conversely, 
dynapaenia can be readily measured using grip dyna-
mometry which is low cost, and commonly available in 
clinical settings. Dynapaenia is a component of the frailty 
syndrome,9 and obesity, measured by both BMI and WC 
has been associated with frailty in older adult popula-
tions.10 The co-occurrence of obesity and dynapaenia 
is termed ‘dynapaenic obesity’ (DO)11 ; the co-occur-
rence of dynapaenia and central or abdominal obesity 
(measured using WC) is termed ‘dynapaenic abdominal 
obesity’ (DAO).12 While both conditions can occur inde-
pendently as a natural part of the ageing process, it has 
been hypothesised that obesity and muscle impairment 
(in this case decreased muscle strength) may be patho-
physiologically connected. Specific mechanisms through 
which obesity may exacerbate the process of dynapaenia 
include decreased physical activity, chronic low-grade 
inflammation, insulin resistance, hormonal changes and 
malnutrition,13 which may also predispose older adults to 
specific health impairments. A recent study on an older 
Italian cohort demonstrated an association between DAO 
and worsening disability and increased risk of hospitalisa-
tion,14 while Batsis et al15 found DO to predict disability, 
functional decline and poorer quality of life in a study 
of US adults aged 45–79 years. Associations with type 2 
diabetes prevalence16 and incidence,17 decreased bone 
mineral density18 and mortality12 have also been shown. 
The increased activity in this area of research in recent 
years necessitates the conduct of a systematic review and 
meta-analysis to determine (1) the frequency of DO in 
older adults and (2) the totality of evidence exploring a 
link between DO and health outcomes in this population.
Objectives
The purpose of this systematic review is to (1) quantify 
the prevalence and incidence of DO in older adult popu-
lations and (2) explore the association between DO and 
health outcomes, specifically (a) chronic disease and 
multimorbidity, (b) functional disability and (c) health-
care usage.
MEthOdOlOgy
This protocol has been prepared following the Preferred 
Reporting Items for Systematic review and Meta-Analysis 
Protocols 2015 checklist19 (online supplementary file 
1), and has been registered with the international 
prospective register of systematic reviews (PROSPERO) 
database. Any protocol amendments will be declared 
in PROSPERO as they occur. The proposed systematic 
review and meta-analysis will be carried out according to 
Meta-analyses Of Observational Studies in Epidemiology 
guidelines.20
Eligibility criteria
We will include observational studies of older adult 
populations using either cross-sectional or longitudinal 
(prospective or retrospective) designs. The Population, 
Risk factor, Outcome framework has been employed to 
define eligibility criteria as outlined below.
Population
 Our target study population is adults aged 50 years and 
older.
Risk factor
The risk factor or exposure of interest for this review is 
DO or DAO). Studies with objective measures of obesity 
(classified according to BMI and/or WC) and muscle 
strength (measured by hand grip or knee dynamometry) 
will be included.
Outcome
Prevalence and/or incidence of DO/DAO will be 
recorded as a percentage (%) with 95% CI. Further 
outcomes of interest are the association between:
DO/DAO and chronic disease
Chronic disease will be defined as the presence of doctor 
diagnosed, long term health conditions. Several defi-
nitions of comorbidity and multimorbidity exist in the 
literature and all will be considered for inclusion in this 
review.
DO/DAO and functional disability
Studies which use a validated measure of disability, such 
as walking speed, the 36-item short-form health survey,21 
the Katz activities of daily living ability scale22 or Lawton 
Instrumental Activities of Daily Living,23 will be included 
in the review.
DO/DAO and healthcare usage
Specific indicators of healthcare usage will include 
general practitioner or family physician visits, outpatient 
and emergency department visits and hospital admissions.
search strategy
A detailed literature search will be conducted in six elec-
tronic databases; Excerpta Medica dataBASE  (EMBASE), 
PubMed, MEDLINE, SCOPUS, ScienceDirect and Cumu-
lative Index of Nursing and Allied Health Complete. Grey 
literature including conference proceedings and institu-
tional repositories will also be searched. The reference 
lists of included articles will be hand searched. Medical 
Subject Headings and synonyms relating to the study 
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objectives will be used to target our search. Searches will 
be restricted to studies published in the English language 
using human subjects only. Articles published from data-
base inception until February 2019 will be included in the 
review. A preliminary EMBASE search strategy has been 
developed in conjunction with the University of Limerick 
Faculty of Education and Health Sciences librarian and 
is detailed in online supplementary file 2. This strategy 
will be adapted and refined for each of the remaining 
databases.
data extraction
A detailed record of all search strategies and results will 
be maintained to ensure reproducibility of the review. 
All results will be imported into the Rayyan citation 
management software,24 where duplicate citations will be 
screened and removed. A three stage reviewing process 
will be employed. Two reviewers (SL and RG) will screen 
all retrieved titles against the stated eligibility criteria. 
Following this, both reviewers (SL and RG) will inde-
pendently screen all selected abstracts. SL and RG will 
then independently review the full text of included arti-
cles. A third reviewer (MC) will adjudicate on disagree-
ments at all stages of the review process.
The following information will be extracted from 
included articles using a proforma template:
Study characteristics:
 ► Study design.
 ► Study location and setting.
 ► Sample size.
 ► Inclusion and exclusion criteria.
 ► Definition of risk factor/exposure, that is, whether 
DO or DAO was measured and what measurement 
tools were used.





 ► Prevalence/incidence of DO/DAO.
 ► Outcomes (association with disease/disability/health-
care usage).
Assessing study quality
The Newcastle Ottawa Scale for quality assessment of 
non-randomised studies25 will be used independently by 
two reviewers (SL and RG) to assess risk of bias and to rate 
study quality. Disagreements will be adjudicated by a third 
reviewer (MC).
data synthesis
Initial analysis will extract data on prevalence and/or 
incidence of DO/DAO from the included studies. Studies 
will then be grouped according to the three outcomes of 
interest: (1) association with chronic disease burden, (2) 
association with functional disability and (3) association 
with indicators of healthcare usage. These groupings may 
not be mutually exclusive.
A narrative synthesis will be conducted to summarise 
the characteristics of the included studies. If possible, a 
random effects meta-analysis of included studies will be 
carried out in consultation with a statistician. Outcomes 
will be recorded as crude or adjusted risk ratio or crude 
or adjusted OR with 95% CI, depending on the study 
type. Variables used to derive adjusted estimates will 
be recorded where relevant. In cases where CIs are not 
provided, variance estimates will be derived from p values 
as per standard methods.26 Data will be pooled using 
Review Manager V.5.2, developed by the Cochrane Collab-
oration.27 Forest plots will be generated and the pooled 
estimates of effect will be suppressed as required. Publi-
cation bias (eg, Kendall’s tau) and heterogeneity (eg, the 
I2 statistic) will also be examined. Subgroup analysis by 
sex, age group (eg, 50–64 years, 65 years+), DO definition 
(DO, DAO) and study design will be performed where 
possible. Finally, a sensitivity check will be conducted to 
determine the consistency and robustness of the find-
ings based on the methodological quality of the included 
studies.
The Grading of Recommendations, Assessment, Devel-
opment and Evaluation guideline will be used to assess 
the strength of the body of evidence, as recommended by 
the Cochrane Handbook.28
Ethics and dissemination
This review constitutes secondary analysis of existing data 
and does not require ethical approval. The findings of 
this research will be submitted for peer-reviewed publica-
tion in academic journals, and presented at relevant semi-
nars and conferences and through traditional and social 
media channels.
Patient and public involvement
Patients and public will not be involved in this study. The 
research questions addressed in this review arose from 
clinical observations of older adults. We anticipate that 
the findings of this review (which represents Phase I of 
the Medical Research Council framework for developing 
and evaluating complex interventions29) will aid in the 
design of a pilot intervention to address the older popula-
tion at risk of DO and associated adverse health outcomes. 
These subsequent phases will have a strong patient and 
public involvement (PPI) component.
dIsCussIOn/COnClusIOn
This systematic review will synthesise existing evidence 
to quantify the prevalence and incidence of DO and 
associated health outcomes in older adult populations. 
This will help to establish if DO/DAO is a significant risk 
factor for poor health outcomes in older adults, and may 
contribute to the design of future primary care interven-
tions to target those most at risk of this phenotype and its 
negative effects.
There are a number of potential strengths and limita-
tions to the planned review that will be considered when 
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discussing the findings. Heterogeneity between studies, 
in terms of methodologies and outcome measures used, 
may limit our ability to conduct a meta-analysis or to 
draw reliable conclusions from the available evidence. 
Restricting included articles to the English language 
is also a potential limitation. The use of observational 
studies is a strength of our review as there is likely to be 
large sample sizes more likely to be representative of the 
overall population, aiding generalisability of the results. 
Our adherence to established guidelines for the conduct 
of systematic reviews and critical appraisal will also ensure 
the quality of the final review.
To the best of our knowledge, no reviews have been 
previously published exploring this research question. 
Should a relevant review be published during the prepa-
ration of our review, it will be incorporated into our 
review and meta-analysis if feasible.
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